TY - JOUR
T1 - Volume-outcome relationship in complication-related mortality after percutaneous coronary interventions
T2 - an analysis on the failure-to-rescue rate in the Japanese Nationwide Registry
AU - Ando, Tomo
AU - Yamaji, Kyohei
AU - Kohsaka, Shun
AU - Fukutomi, Motoki
AU - Onishi, Takayuki
AU - Inohara, Taku
AU - Ishii, Hideki
AU - Amano, Tetsuya
AU - Ikari, Yuji
AU - Tobaru, Tetsuya
N1 - Funding Information:
K.Y. reports investigator-initiated grant funding from Abbott. H.I. received lecture fees from Astellas Pharma, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Mochida Pharma, Novartis Pharma, and Otsuka Pharma. T.A. receives lecture fees from Astellas Pharma, AstraZeneca, Bayer, Daiichi Sankyo, and Bristol-Myers Squibb. The rest of the authors have no conflict of interest to report. S.K. has received an unrestricted research grant from the Department of Cardiology, Keio University School of Medicine, Bayer Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., and Novartis Pharmaceutical Co., Ltd. All other authors have no related disclosures.
Publisher Copyright:
© 2023, The Author(s) under exclusive licence to Japanese Association of Cardiovascular Intervention and Therapeutics.
PY - 2023
Y1 - 2023
N2 - In-hospital mortality following percutaneous coronary intervention (PCI) varies across institutions with different annual PCI volumes. The failure to rescue (FTR) rate, defined as the mortality rate following PCI-related complications, may account for the volume-outcome relationship. The Japanese Nationwide PCI Registry, a consecutive, nationally mandated registry between 2019 and 2020, was queried. The FTR rate is defined as ‘the number of patients who died following PCI-related complications’ divided by ‘the number of patients who experienced at least one PCI-related complication.’ Multivariate analysis was used to calculate the risk-adjusted odds ratio (aOR) of the FTR rates among hospitals stratified into tertiles as low (≤ 236/year), medium (237–405/year), and high (≥ 406/year). A total of 465,716 PCIs and 1007 institutions were included. A volume-outcome relationship was observed for in-hospital mortality, and the medium-volume (aOR 0.90, 95% confidence interval [CI] 0.85–0.96), as well as high-volume (aOR 0.84, 95% CI 0.79–0.89) hospitals, had significantly lower in-hospital mortality than low-volume hospitals. Complication rates were lower at high-volume centers (1.9%, 2.2%, and 2.6% for high-, medium-, and low-volume centers, respectively; p < 0.001). The overall FTR rate was 19.0%. The FTR rates for the low-, medium-, and high-volume hospitals were 19.3%, 17.7%, and 20.6%, respectively. The medium-volume hospitals had a lower FTR rate (aOR 0.82, 95% [CI] 0.68–0.99), whereas the FTR rate was similar at the high-volume hospitals compared with that of the low-volume hospitals (aOR 1.02, 95% CI 0.83–1.26). In-hospital mortality was low after PCI in high-volume hospitals. However, the FTR rate in high-volume hospitals was not necessarily lower than that in low-volume hospitals. The FTR rate did not account for the volume-outcome relationship in PCI.
AB - In-hospital mortality following percutaneous coronary intervention (PCI) varies across institutions with different annual PCI volumes. The failure to rescue (FTR) rate, defined as the mortality rate following PCI-related complications, may account for the volume-outcome relationship. The Japanese Nationwide PCI Registry, a consecutive, nationally mandated registry between 2019 and 2020, was queried. The FTR rate is defined as ‘the number of patients who died following PCI-related complications’ divided by ‘the number of patients who experienced at least one PCI-related complication.’ Multivariate analysis was used to calculate the risk-adjusted odds ratio (aOR) of the FTR rates among hospitals stratified into tertiles as low (≤ 236/year), medium (237–405/year), and high (≥ 406/year). A total of 465,716 PCIs and 1007 institutions were included. A volume-outcome relationship was observed for in-hospital mortality, and the medium-volume (aOR 0.90, 95% confidence interval [CI] 0.85–0.96), as well as high-volume (aOR 0.84, 95% CI 0.79–0.89) hospitals, had significantly lower in-hospital mortality than low-volume hospitals. Complication rates were lower at high-volume centers (1.9%, 2.2%, and 2.6% for high-, medium-, and low-volume centers, respectively; p < 0.001). The overall FTR rate was 19.0%. The FTR rates for the low-, medium-, and high-volume hospitals were 19.3%, 17.7%, and 20.6%, respectively. The medium-volume hospitals had a lower FTR rate (aOR 0.82, 95% [CI] 0.68–0.99), whereas the FTR rate was similar at the high-volume hospitals compared with that of the low-volume hospitals (aOR 1.02, 95% CI 0.83–1.26). In-hospital mortality was low after PCI in high-volume hospitals. However, the FTR rate in high-volume hospitals was not necessarily lower than that in low-volume hospitals. The FTR rate did not account for the volume-outcome relationship in PCI.
KW - Failure to rescue
KW - Hospital volume
KW - Percutaneous coronary intervention
UR - http://www.scopus.com/inward/record.url?scp=85153530740&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85153530740&partnerID=8YFLogxK
U2 - 10.1007/s12928-023-00935-w
DO - 10.1007/s12928-023-00935-w
M3 - Article
AN - SCOPUS:85153530740
SN - 1868-4300
VL - 38
SP - 388
EP - 394
JO - Cardiovascular Intervention and Therapeutics
JF - Cardiovascular Intervention and Therapeutics
IS - 4
ER -